Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001019687-15-003969
Filing Date
2015-11-10
Accepted
2015-11-10 08:00:20
Documents
10
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10Q proteo_10q-093015.htm 10-Q 174650
2 CERTIFICATION proteo-ex3101.htm EX-31.1 9032
3 CERTIFICATION proteo-ex3102.htm EX-31.2 8986
4 CERTIFICATION proteo-ex32.htm EX-32 5114
  Complete submission text file 0001019687-15-003969.txt   980295

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE pteo-20150930.xml EX-101.INS 87278
6 XBRL SCHEMA FILE pteo-20150930.xsd EX-101.SCH 12897
7 XBRL CALCULATION FILE pteo-20150930_cal.xml EX-101.CAL 27118
8 XBRL DEFINITION FILE pteo-20150930_def.xml EX-101.DEF 18067
9 XBRL LABEL FILE pteo-20150930_lab.xml EX-101.LAB 90699
10 XBRL PRESENTATION FILE pteo-20150930_pre.xml EX-101.PRE 71131
Mailing Address 2102 BUSINESS CENTER DRIVE IRVINE CA 92612
Business Address 2102 BUSINESS CENTER DRIVE IRVINE CA 92612 949-253-4616
PROTEO INC (Filer) CIK: 0001063104 (see all company filings)

EIN.: 880292249 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-30728 | Film No.: 151217397
SIC: 2834 Pharmaceutical Preparations